Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Circ Genom Precis Med. 2018 Jun;11(6):e002098. doi: 10.1161/CIRCGEN.117.002098

Table 5.

HRs (95% CIs) of Incident Ischemic Stroke, CHD, and the Composite Outcome Comparing 2 vs 0 or 1 APOL1 Risk Variants (Recessive Model), Stratified by CKD Status

Events/Total N (%) Crude, HR (95% CI) Model 1, HR(95% CI) Model 2, HR (95% CI)
No CKD
 Ischemic stroke* 211/7098 (3%) 1.26 (0.86–1.84) 1.35 (0.92–1.98) 1.79 (1.04–3.07)
 CHD 186/6557 (3%) 1.17 (0.77–1.77) 1.19 (0.78–1.80) 0.97 (0.56–1.70)
 Composite events 300/6125 (5%) 1.17 (0.85–1.62) 1.22 (0.88–1.70) 1.20 (0.77–1.87)
CKD
 Ischemic stroke* 158/2315 (7%) 0.79 (0.49–1.26) 0.83 (0.51–1.35) 0.77 (0.36–1.61)
 CHD 137/2033 (7%) 0.95 (0.59–1.53) 0.99 (0.60–1.62) 0.99 (0.55–1.79)
 Composite events 200/1783 (11 %) 0.97 (0.6–1.43) 1.04 (0.70–1.56) 1.10 (0.65–1.85)

Model 1 adjusted for age, sex, smoking, hypertension, lipid-lowering medications, and diabetes mellitus (CKD, events/N: stroke=152/2228; CHD=133/1953; composite=194/1712; no CKD, events/N: stroke=205/6947; CHD=184/6428; composite=296/6007). Model 2 adjusted for variables in model 1 plus ancestry principal components (CKD, events/N: stroke=66/1561; CHD=98/1405; composite=112/1230; no CKD, events/N: stroke=86/4788; CHD=123/4489; composite=161/4205). Pinteraction for CKD on the association of APOL1 high-risk status with incident stroke, CHD, and the composite outcome in the fully adjusted model (model 2) were 0.04, 0.90, and 0.69, respectively. CKD (defined as an estimated glomerular filtration rate <60 mL/min per 1.73 m2 or a spot urine albumin-to-creatinine ratio ≥30 mg/g). CHD indicates coronary heart disease; CI, confidence interval; CKD, chronic kidney disease; and HR, hazard ratio.

*

Excludes prevalent stroke, hemorrhagic, and nonadjudicated strokes.

Excludes prevalent coronary heart disease.

Excludes prevalent stroke, hemorrhagic strokes, nonadjudicated strokes, and prevalent coronary heart disease.